CHANGSHA, China, Aug. 5, 2021 /PRNewswire/ -- Recently, Micomme
has associated with Polish and Peruvian partners to accomplish the
government centralized purchase of 1,600 and 1,500 units of
HFNC respectively. Both purchases are strategic material reserves
of the local governments. The global pandemic is still ongoing, and
the safety of people's lives is the primary goal pursued by
governments. The projects also reflect the foresight and
determination of the local governments. Both purchases were
delivered in June 2021.
As the leading non-invasive respiratory therapy company in
China, Micomme Medical launched
their first transnasal High-Flow Nasal Cannula Oxygen Therapy
Device (hereinafter referred to as HFNC) OH-70C in 2017. At the
beginning of the pandemic outbreak, Micomme Medical responded
quickly during the traditional Chinese Spring Festival. All
employees returned to work from holiday, the production line was
fully activated, and more than 5,000 units of HFNC were sent to
Wuhan immediately. In 2020,
Micomme achieved more than 10,000 HFNC installations worldwide
(China not included), and helped
countries around the world fight against COVID-19 with a production
capacity of 500 units per day.
The transnasal High-Flow Nasal Cannula Oxygen Therapy Device
is the machine recommended by WHO and related international
guidelines for the treatment of patients with COVID-19. It aims to
quickly increase the patient's oxygen saturation (SpO2) and improve
the symptoms of hypoxia in patients by providing a high-flow
air-oxygen mixed gas to patients with a constant temperature,
humidity and a constant oxygen concentration. As one of the first
HFNC manufacture in China, Micomme
has won the market's recognition with its excellent product quality
and brilliant product performance. In the battle against COVID-19,
Micomme fulfills the commitment as the leading company.
For more details, please contact: market.intl@micomme.com
Reference:
www.who.int/publications/i/item/clinical-care-of-severe-acute-respiratory-infections-tool-kit
www.who.int/publications/i/item/technical-specifications-for-invasive-and-non-invasive-ventilaotrs-for-covid-19